insights_auto
Why is AZN up 4,27%?
Dive Deeperchevron_right
AZN:NYSE
ແອັດສຕຣາເຊເນກ້າ
US$162,47
arrow_upward
+4,27%(+6,65) 1D
14 ຕ.ລ., 13 ໂມງ 21 ນາທີ 34 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZN...
Open
US$158,71
High
US$162,51
Low
US$158,31
Mkt. cap
254,95 ຕື້
Avg. vol.
2,91 ລ້ານ
Volume
1,47 ລ້ານ
Dividend
1,98%
Quarterly dividend
US$0,81
Ex-dividend date
6 ສ.ຫ. 2026
P/E ratio
24,29
52-wk high
US$212,71
52-wk low
US$80,48
EPS
US$6,69
Beta
0,30
Shares outstanding
1,55 ຕື້
No. of employees
96 ພັນ
Open
US$158,71
High
US$162,51
Low
US$158,31
Mkt. cap
254,95 ຕື້
Avg. vol.
2,91 ລ້ານ
Volume
1,47 ລ້ານ
Dividend
1,98%
Quarterly dividend
US$0,81
Ex-dividend date
6 ສ.ຫ. 2026
P/E ratio
24,29
52-wk high
US$212,71
52-wk low
US$80,48
EPS
US$6,69
Beta
0,30
Shares outstanding
1,55 ຕື້
No. of employees
96 ພັນ
News stories
From web sources and news partners
TipRanks
·
36 ນາທີກ່ອນ
AstraZeneca’s LAZURE Trial Signals Next Step in Cholesterol Treatment
Timothy Sykes
·
49 ນາທີກ່ອນ
AstraZeneca Stock Draws Bullish Targets As Oncology Deals Pile Up
StocksToTrade
·
49 ນາທີກ່ອນ
AstraZeneca PLC Stock Draws Upgrades As Oncology Deals Accelerate
Quiver Quantitative
·
1 ຊົ່ວໂມງກ່ອນ
Why AstraZeneca (AZN) Stock Is Up Today
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About ແອັດສຕຣາເຊເນກ້າ
CEOPascal Soriot
Employees96,1 ພັນ
Founded6 ມ.ສ. 1999
HeadquartersCambridge, Cambridgeshire, ສະຫະລາດຊະອະນາຈັກ
SectorPharmaceutical industry
Websiteastrazeneca.com